Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

COL9A3 antibody (AA 501-528)

COL9A3 Reactivity: Human WB Host: Rabbit Polyclonal RB42519 unconjugated
Catalog No. ABIN1881221
  • Target See all COL9A3 Antibodies
    COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))
    Binding Specificity
    • 6
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 501-528
    Reactivity
    • 25
    • 11
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Human
    Host
    • 24
    • 2
    Rabbit
    Clonality
    • 25
    • 1
    Polyclonal
    Conjugate
    • 14
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    This COL9A3 antibody is un-conjugated
    Application
    • 15
    • 13
    • 4
    • 3
    • 1
    Western Blotting (WB)
    Purification
    This antibody is purified through a protein A column, followed by peptide affinity purification.
    Immunogen
    This COL9A3 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 501-528 amino acids from the Central region of human COL9A3.
    Clone
    RB42519
    Isotype
    Ig Fraction
    Top Product
    Discover our top product COL9A3 Primary Antibody
  • Application Notes
    WB: 1:1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Preservative
    Sodium azide
    Precaution of Use
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    4 °C,-20 °C
    Expiry Date
    6 months
  • Videman, Saarela, Kaprio, Näkki, Levälahti, Gill, Peltonen, Battié: "Associations of 25 structural, degradative, and inflammatory candidate genes with lumbar disc desiccation, bulging, and height narrowing." in: Arthritis and rheumatism, Vol. 60, Issue 2, pp. 470-81, (2009) (PubMed).

    Karppinen, Daavittila, Solovieva, Kuisma, Taimela, Natri, Haapea, Korpelainen, Niinimäki, Tervonen, Ala-Kokko, Männikkö: "Genetic factors are associated with modic changes in endplates of lumbar vertebral bodies." in: Spine, Vol. 33, Issue 11, pp. 1236-41, (2008) (PubMed).

    Decramer, Bascands, Schanstra: "Non-invasive markers of ureteropelvic junction obstruction." in: World journal of urology, Vol. 25, Issue 5, pp. 457-65, (2007) (PubMed).

    Virtanen, Karppinen, Taimela, Ott, Barral, Kaikkonen, Heikkilä, Mutanen, Noponen, Männikkö, Tervonen, Natri, Ala-Kokko: "Occupational and genetic risk factors associated with intervertebral disc disease." in: Spine, Vol. 32, Issue 10, pp. 1129-34, (2007) (PubMed).

  • Target
    COL9A3 (Collagen, Type IX, alpha 3 (COL9A3))
    Alternative Name
    COL9A3 (COL9A3 Products)
    Background
    This gene encodes one of the three alpha chains of type IX collagen, the major collagen component of hyaline cartilage. Type IX collagen, a heterotrimeric molecule, is usually found in tissues containing type II collagen, a fibrillar collagen. Mutations in this gene are associated with multiple epiphyseal dysplasia type 3.
    Molecular Weight
    63616
    NCBI Accession
    NP_001844
    UniProt
    Q14050
You are here:
Support